Cambrex Appoints Tom Vadaketh as Executive Vice President

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
181
Cambrex Appoints Tom Vadaketh as Executive Vice President and Chief Financial Officer

EAST RUTHERFORD, N.J., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), a leading manufacturer of small molecule Active Pharmaceutical Ingredients (APIs), today announced the hiring of Tom Vadaketh as Executive Vice President and Chief Financial Officer, effective January 20, 2017.  Greg Sargen, CFO at Cambrex, will transition to a newly-created role, Executive Vice President, Corporate Development and Strategy.  In his new role, Mr. Sargen will assume responsibility for Corporate Development and Strategy and will continue to report directly to Steven M. Klosk, President and Chief Executive Officer.

“We are excited to welcome Tom. He has an impressive track record and brings a wide variety of experiences across all financial disciplines to Cambrex,” said Mr. Klosk.  “I am confident that Tom’s experience in senior corporate roles, especially with manufacturing organizations and facilities, will be invaluable to Cambrex.  Tom and Greg will work closely together to ensure a seamless transition.”

“2016 has been our sixth consecutive year of strong organic growth, and we have invested well over $200 million in internal expansions during that time. As we look to the future, we recognize the need to complement our organic efforts with external opportunities,” continued Mr. Klosk.  “Greg has led the finance team and has been a trusted business partner during his many years at Cambrex.  In his new role, Greg will apply his business acumen, industry knowledge and intimate knowledge of the Company to identify and execute on new growth opportunities, including investment in potential new product categories and capabilities, as well as mergers and acquisitions.” 

Mr. Vadaketh was most recently the CFO of the Crosby Group, a private equity-owned company and a world leader in the manufacture of rigging, lifting and material handling applications.  Prior to that, he spent nine years in a variety of increasingly senior financial positions at Tyco International.  In his last role at Tyco, he served as Vice President, Finance, Corporate Financial Planning & Analysis and CFO of Global Products.  Prior to his time at Tyco, Mr. Vadaketh spent 15 years in a variety of senior financial roles at Proctor & Gamble, where he led several corporate and site financial functions and initiatives.  Tom started his career at Deloitte and Touche in the United Kingdom, where he earned the Chartered Accountant designation. He also earned his CPA designation in the United States.  Tom has a Master of Business Administration (MBA) from the University of Manchester, United Kingdom.

About Cambrex Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances.  For more information, please visit www.cambrex.com .

Contact: Stephanie LaFiura Investor Relations Associate Tel: 201-804-3037 Email: stephanie.lafiura@cambrex.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 226

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Vector's Peptide Pact Needs Proof Before Any Payday

Updated Category News Views 174

A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...

Continue Reading
Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 116

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
Lummus-Versalis Deal Adds Nine Elastomer Technologies

Updated Category News Views 93

Nine elastomer technologies do not make a flashy headline, yet this is the sort of chemical-industry move that can matter long after the applause dies down. Lummus Technology and Versalis have expanded their partnership to cover nine elastomer technologies. That is the disclosed fact, and it is meaningful on its own. The release does not lay out contract value, duration,...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 62

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading
AMP Tests Debt Market With €1.25 Billion Green Notes

Updated Category News Views 167

Refinancing season has arrived early at Ardagh Metal Packaging, and it is carrying a hefty €1.25 billion price tag. AMP has launched senior secured floating-rate green notes, with proceeds intended to retire two batches of secured debt due in 2028 and leave additional cash on the balance sheet for general corporate purposes, including capital expenditure. This is not...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 49

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
Scenthound’s Franchise Award Spotlights a Real Test

Updated Category News Views 30

A clean dog may not sound like a growth story, yet Scenthound has turned that neglected chore into a surprisingly serious franchise proposition. The company has won the International Franchise Association’s Emerging Franchisor Award after building its dog-hygiene concept from a 2015 founding into a network with more than 180 open locations. That is a respectable piece...

Continue Reading
Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 201

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
BetterInvesting Puts ELMD and FIVE Under a Fresh Lens

Updated Category News Views 74

Two familiar market traps are hiding in this otherwise useful announcement: mistaking a study candidate for a buy signal, and treating the word undervalued like it fell from a mountaintop. BetterInvesting has named Electromed Inc. as its “Stock to Study” and Five Below Inc. as its “Undervalued Stock” for the January-February 2027 issue of its magazine. That is...

Continue Reading

Top 5 Most Recently Viewed Articles

ChargePoint Faces Share Decline Following Q2 Financial Report

Updated Category News Views 67

Overview of ChargePoint's Stock Performance ChargePoint Holdings Inc (NYSE: CHPT) has seen a drop in its stock value following the release of disappointing financial results for the second quarter. Investors are carefully examining the details of the report, which highlighted significant challenges the company faced during this time. Q2 Financial Highlights In the second...

Continue Reading
Exciting March Madness Audio Coverage by Westwood One 2025

Updated Category News Views 244

Comprehensive Audio Coverage of NCAA Men's Basketball Tournament As the NCAA Men's Basketball Tournament approaches, fans are gearing up for what promises to be an exciting series of games. This year, Cumulus Media's Westwood One (NASDAQ: CMLS) will provide exclusive multiplatform audio coverage of the entire tournament, ensuring that fans can enjoy every moment, whether...

Continue Reading
Cartesian Therapeutics Advances Myasthenia Gravis Treatment Trials

Updated Category News Views 118

Advancements in Myasthenia Gravis Treatment by Cartesian Therapeutics Cartesian Therapeutics, Inc. (NASDAQ: RNAC), a pioneering company in mRNA cell therapy, is making significant strides in developing groundbreaking treatments for autoimmune diseases, especially myasthenia gravis (MG). With encouraging updates from the Phase 2b trial of their leading candidate,...

Continue Reading
Centrifuge Market Set to Surpass $689 Million Amid Growth

Updated Category News Views 147

Growth of the Centrifuge Market: An In-Depth Analysis The centrifuge market is undergoing a remarkable transformation, with projections indicating an increase from USD 463 million in 2023 to an impressive USD 689.91 million by 2032. This growth is driven by a compound annual growth rate (CAGR) of 4.53% from 2024 to 2032, fueled by advancements in biotechnology,...

Continue Reading
National Bank Holdings Sees Price Target Increase by Piper Sandler

Updated Category News Views 58

Piper Sandler Raises Price Target for National Bank Holdings Piper Sandler has recently reviewed its financial outlook for National Bank Holdings (NYSE: NBHC), making a significant update to its price target. The new target has been set at $48.00, an increase from the previous target of $44.00. Current Stock Rating and Rationale The firm has maintained a Neutral rating on...

Continue Reading